Back

Effects of the glucagon like peptide- 1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment.

27 August 2018 (17:17 - 17:31)
Organised by:
Congress Presentation Part of: Diabetes - The malfunction of the "sweet heart" Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Diabetes and malfunction of the heart - Current knowledge
Professor R. Ritchie (Melbourne, AU)
Presentation thumbnail
Non-ischemic myocardial lesions in type 2 diabetes mellitus as assessed by late gadolinium enhancement magnetic resonance imaging: a cohort study of lesion types and prevalence
Doctor A. Bojer (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus?
Doctor A. Bosch (Erlangen, DE)
Abstract

Access the full session

Session thumbnail
Diabetes - The malfunction of the "sweet heart"

The Event

Event poster

ESC Congress 2018

27 August 2018 17:17 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources